1. Boguszewski MCS, Boguszewski CL, Chemaitilly W, Cohen LE, Gebauer J, Higham C, Hoffman AR, Polak M, Yuen KCJ, Alos N, Antal Z, Bidlingmaier M, Biller BMK, Brabant G, Choong CSY, Cianfarani S, Clayton PE, Coutant R, Cardoso-Demartini AA, Fernandez A, Grimberg A, Guðmundsson K, Guevara-Aguirre J, Ho KKY, Horikawa R, Isidori AM, Jørgensen JOL, Kamenicky P, Karavitaki N, Kopchick JJ, Lodish M, Luo X, McCormack AI, Meacham L, Melmed S, Mostoufi Moab S, Müller HL, Neggers SJCMM, Aguiar Oliveira MH, Ozono K, Pennisi PA, Popovic V, Radovick S, Savendahl L, Touraine P, van Santen HM, Johannsson G. Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement. Eur J Endocrinol. 2022 Apr 21;186(6):P35-P52. doi: 10.1530/EJE-21-1186. PMID: 35319491; PMCID: PMC9066587. IF 6.558
2. Bidlingmaier M, Gleeson H, Latronico AC, Savage MO. Applying precision medicine to the diagnosis and management of endocrine disorders. Endocr Connect. 2022 Sep 2;11(10):e220177. doi: 10.1530/EC-22-0177. PMID: 35968864; PMCID: PMC9513637. IF 3.221
3. Bidlingmaier M, Biller BMK, Clemmons D, Jørgensen JOL, Nishioka H, Takahashi Y. Guidance for the treatment of adult growth hormone deficiency with somapacitan, a long-acting growth hormone preparation. Front Endocrinol (Lausanne). 2022 Dec 23;13:1040046. doi: 10.3389/fendo.2022.1040046. Erratum in: Front Endocrinol (Lausanne). 2023 Mar 02;14:1158214. PMID: 36619571; PMCID: PMC9816378. IF 6.055
4. Bidlingmaier M, Valcour A, Schilbach K, Kuehnle T, Diederich S, Rogge T, Cavalier E, Katayev A. Differences in the Distribution of IGF-I Concentrations Between European and US Populations. J Endocr Soc. 2022 May 19;6(7):bvac081. doi: 10.1210/jendso/bvac081. PMID: 35673402; PMCID: PMC9165432. IF 3.487
5. Hintze S, Baber L, Hofmeister F, Jarmusch S, Todorow V, Mehaffey S, Tanganelli F, Ferrari U, Neuerburg C, Teupser D, Bidlingmaier M, Marques JG, Koletzko B, Schoser B, Drey M, Meinke P. Exploration of mitochondrial defects in sarcopenic hip fracture patients. Heliyon. 2022 Oct 19;8(10):e11143. doi: 10.1016/j.heliyon.2022.e11143. PMID: 36303924; PMCID: PMC9593198. IF 3.776
6. Eisenhofer G, Kurlbaum M, Peitzsch M, Constantinescu G, Remde H, Schulze M, Kaden D, Müller LM, Fuss CT, Kunz S, Kołodziejczyk-Kruk S, Gruber S, Prejbisz A, Beuschlein F, Williams TA, Reincke M, Lenders JWM, Bidlingmaier M. The Saline Infusion Test for Primary Aldosteronism: Implications of Immunoassay Inaccuracy. J Clin Endocrinol Metab. 2022 Apr 19;107(5):e2027-e2036. doi: 10.1210/clinem/dgab924. PMID: 34963138; PMCID: PMC9016451. IF 6.134
7. Asbach E, Kellnar A, Bekeran M, Schelling J, Bidlingmaier M, Reincke M. Prevalence of Primary Aldosteronism in Newly Diagnosed Hypertensive Patients in Primary Care. Exp Clin Endocrinol Diabetes. 2022 Dec;130(12):801-805. doi: 10.1055/a-1938-4242. Epub 2022 Sep 7. PMID: 36070803. IF 2.426
8. Nowotny HF, Braun L, Vogel F, Bidlingmaier M, Reincke M, Tschaidse L, Auer MK, Lottspeich C, Wudy SA, Hartmann MF, Hawley J, Adaway JE, Keevil B, Schilbach K, Reisch N. 11-Oxygenated C19 steroids are the predominant androgens responsible for hyperandrogenemia in Cushing's disease. Eur J Endocrinol. 2022 Sep 29;187(5):663-673. doi: 10.1530/EJE-22-0320. PMID: 36074938; PMCID: PMC9578081. IF 6.558
9. Dubinski I, Bechtold S, Bidlingmaier M, Reisch N, Schmidt H. Salivary 17-hydroxyprogesterone levels in children with congenital adrenal hyperplasia - a retrospective longitudinal study considering auxological parameters. Horm Res Paediatr. 2022 Aug 12. doi: 10.1159/000526485. Epub ahead of print. PMID: 35960318. IF 4.275
10. Zhang R, Rubinstein G, Vetrivel S, Kunz S, Vogel F, Bouys L, Bertherat J, Kroiss M, Deniz S, Osswald A, Knösel T, Bidlingmaier M, Sbiera S, Reincke M, Riester A. Steroid profiling using liquid chromatography mass spectrometry during adrenal vein sampling in patients with primary bilateral macronodular adrenocortical hyperplasia. Front Endocrinol (Lausanne). 2022 Dec 6;13:1079508. doi: 10.3389/fendo.2022.1079508. PMID: 36561559; PMCID: PMC9763872. IF 6.055
11. Rubinstein G, Osswald A, Braun LT, Vogel F, Kroiss M, Pilz S, Deniz S, Aigner L, Knösel T, Bertherat J, Bouys L, Ladurner R, Riester A, Bidlingmaier M, Beuschlein F, Reincke M. The role of adrenal venous sampling (AVS) in primary bilateral macronodular adrenocortical hyperplasia (PBMAH): a study of 16 patients. Endocrine. 2022 May;76(2):434-445. doi: 10.1007/s12020-022-03020-z. Epub 2022 Mar 10. PMID: 35274284; PMCID: PMC9068666. IF 3.925
12. Kern-Matschilles S, Gar C, Schilbach K, Haschka SJ, Rauch B, Then C, Seissler J, Bidlingmaier M, Lechner A. Altered Circulating Leptin, hGH, and IGF-I in Prediabetes and Screening-Diagnosed T2DM Unrelated to Metabolic Syndrome in Women Post Gestational Diabetes. Horm Metab Res. 2022 Sep;54(9):613-619. doi: 10.1055/a-1850-5392. Epub 2022 May 12. PMID: 35556239. IF 2.788
13. Then C, Ritzel K, Herder C, Then H, Sujana C, Heier M, Meisinger C, Peters A, Koenig W, Rathmann W, Roden M, Maalmi H, Stumvoll M, Meitinger T, Bidlingmaier M, Seissler J, Thorand B, Reincke M. Association of renin and aldosterone with glucose metabolism in a Western European population: the KORA F4/FF4 study. BMJ Open Diabetes Res Care. 2022 Jan;10(1):e002558. doi: 10.1136/bmjdrc-2021-002558. PMID: 35086943; PMCID: PMC8796222. IF 4.186
14. Braun LT, Vogel F, Zopp S, Rubinstein G, Schilbach K, Künzel H, Beuschlein F, Reincke M. Diurnal Salivary Cortisol Profiles in Patients with Cushing's Syndrome. Exp Clin Endocrinol Diabetes. 2022 Jul;130(7):434-438. doi: 10.1055/a-1719-5381. Epub 2022 Jan 17. PMID: 35038761. IF 2.426
15. Albani A, Perez-Rivas LG, Tang S, Simon J, Lucia KE, Colón-Bolea P, Schopohl J, Roeber S, Buchfelder M, Rotermund R, Flitsch J, Thorsteinsdottir J, Herms J, Stalla G, Reincke M, Theodoropoulou M. Improved pasireotide response in USP8 mutant corticotroph tumours in vitro. Endocr Relat Cancer. 2022 Jun 29;29(8):503-511. doi: 10.1530/ERC-22-0088. PMID: 35686696. IF 5.900
16. Störmann S. Let's focus more on regional diversity of acromegaly. Ann Transl Med. 2022 Aug;10(16):848. doi: 10.21037/atm-22-3653. PMID: 36111053; PMCID: PMC9469124. IF 3.613
17. Donegan D, Saeed Z, Delivanis DA, Murad MH, Honegger J, Amereller F, Oguz SH, Erickson D, Bancos I. Outcomes of Initial Management Strategies in Patients With Autoimmune Lymphocytic Hypophysitis: A Systematic Review and Meta-analysis. J Clin Endocrinol Metab. 2022 Mar 24;107(4):1170-1190. doi: 10.1210/clinem/dgab839. PMID: 35137155; PMCID: PMC8947799. IF 6.558
18. Schulz TU, Zierold S, Sachse MM, Pesch G, Tomsitz D, Schilbach K, Kähler KC, French LE, Heinzerling L. Persistent immune-related adverse events after cessation of checkpoint inhibitor therapy: Prevalence and impact on patients' health-related quality of life. Eur J Cancer. 2022 Nov;176:88-99. doi: 10.1016/j.ejca.2022.08.029. Epub 2022 Oct 2. PMID: 36198246. IF 10.002
